{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:59:01Z","timestamp":1790477941950,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114747","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T20:15:59Z","timestamp":1418415359000},"page":"e114747","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis"],"prefix":"10.1371","volume":"9","author":[{"given":"Lindsay Y.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gudewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Hoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokunbo","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Ufere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan C.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1034\/j.1600-6143.2001.001003197.x","article-title":"Hepatitis C Infection in Liver Transplantation","volume":"1","author":"M Charlton","year":"2001","journal-title":"American Journal of Transplantation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1002\/hep.510260701","article-title":"National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C","volume":"26","year":"1997","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"G D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"H Huang","year":"2007","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"DL Thomas","year":"2009","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2010.07.019","article-title":"IL-28B rs12979860 C\/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC","volume":"54","author":"C Fabris","year":"2011","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Noureddin M, Wright EC, Alter H, Clark S, Thomas E, et al. (2013) Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis. Hepatology.","DOI":"10.1002\/hep.26506"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10875-011-9547-1","article-title":"Role of interleukin 28B rs12979860 C\/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype","volume":"31","author":"E Falleti","year":"2011","journal-title":"J Clin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.2007.65","article-title":"Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis","volume":"299","author":"KK Tanabe","year":"2008","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.gastro.2011.03.045","article-title":"A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma","volume":"141","author":"BK Abu Dayyeh","year":"2011","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cyto.2011.10.018","article-title":"Association between the epidermal growth factor rs4444903 G\/G genotype and advanced fibrosis at a young age in chronic hepatitis C","volume":"57","author":"E Falleti","year":"2012","journal-title":"Cytokine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.23768","article-title":"PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease","volume":"52","author":"EK Speliotes","year":"2010","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.24350","article-title":"Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C","volume":"54","author":"E Trepo","year":"2011","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"L Valenti","year":"2011","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Trepo E, Nahon P, Bontempi G, Valenti L, Falleti E, et al. (2013) Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology.","DOI":"10.1002\/hep.26767"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2012.09.036","article-title":"PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis","volume":"58","author":"E Guyot","year":"2013","journal-title":"Journal of Hepatology"},{"key":"ref18","unstructured":"WHO WHO Expert Committee on Biological Standardization Guidelines for Thromboplastins and Plasma Used to Control Oral Anticoagulant Therapy. WHO Technical Report Series no. 889. Geneva WHO 64\u201393."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.gastro.2009.09.007","article-title":"Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C","volume":"138","author":"MG Ghany","year":"2010","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Y Hoshida","year":"2008","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2013.01.021","article-title":"Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis","volume":"144","author":"Y Hoshida","year":"2013","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"J Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.chom.2013.02.006","article-title":"HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex","volume":"13","author":"L Zona","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1128\/JVI.00750-12","article-title":"Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry","volume":"86","author":"J Diao","year":"2012","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1089\/gtmb.2012.0050","article-title":"Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis","volume":"16","author":"Z Yang","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e32159","DOI":"10.1371\/journal.pone.0032159","article-title":"Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis","volume":"7","author":"JH Zhong","year":"2012","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2249.2011.04497.x","article-title":"Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection","volume":"167","author":"S Cmet","year":"2012","journal-title":"Clinical & Experimental Immunology"},{"key":"ref28","unstructured":"Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, et al. (2013) EGFR inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology: n\/a\u2013n\/a."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T11:49:08Z","timestamp":1566128948000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114747"}},"subtitle":[],"editor":[{"given":"Erica","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114747","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}